ZMB Member Christian Reinhardt
ZMB Member
Christian Reinhardt
Next ZMB-Member
Prof. Dr. Christian Reinhardt
Director of:
Clinic for Hematology and Stem Cell TransplantationWest German Cancer Centre (WTZ)
University Hospital Essen
Hufelandstraße 55
45147 Essen
- +49 201 723 3136
- Website
- Press Releases
- Selected Publications
-

- Publication Metrics
- ZMB Research Program
Oncology
Research Overview
- B cell lymphomas
- Lung Cancer
- Functional Genomics
- DNA Damage
- Transcription factor p53
Selected Publications
-
CSF1R⁺ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphomaIn: Cancer Cell, Vol. 43, 2025, Nr. 8, pp. 1476 – 1494.e10DOI (Open Access)
-
Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8087, pp. 1243 – 1253DOI (Open Access)
-
Publisher Correction : Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8086, pp. E17DOI (Open Access)
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood, Vol. 143, 2024, Nr. 6, pp. 522 – 534
-
Evolutionary trajectories of small cell lung cancer under therapyIn: Nature, Vol. 627, 2024, Nr. 8005, pp. 880 – 889DOI (Open Access)
-
Data-driven grading of acute graft-versus-host diseaseIn: Nature Communications, Vol. 14, 2023, Nr. 1, 7799DOI, Online Full Text (Open Access)
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood, Vol. 142, 2023, Nr. 25, pp. 2175 – 2191DOI (Open Access)
-
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationIn: Blood, Vol. 141, 2023, Nr. 23, pp. 2901 – 2911DOI (Open Access)
-
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaIn: Blood, Vol. 140, 2022, Nr. 10, pp. 1119 – 1131DOI (Open Access)
-
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesIn: Blood, Vol. 140, 2022, Nr. 20, pp. 2113 – 2126DOI (Open Access)
-
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesIn: Blood, Vol. 139, 2022, Nr. 25, pp. 3617 – 3629DOI (Open Access)
-
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaIn: Blood, Vol. 139, 2022, Nr. 4, pp. 538 – 553DOI (Open Access)
-
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1In: Blood, Vol. 137, 2021, Nr. 5, pp. 646 – 660DOI (Open Access)
-
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasIn: Blood, Vol. 137, 2021, Nr. 20, pp. 2785 – 2799DOI (Open Access)
-
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesIn: Cancer Discovery, Vol. 2, 2021, Nr. 1, pp. 70 – 91DOI, Online Full Text (Open Access)
-
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesIn: Nature Communications, Vol. 12, 2021, Nr. 1, 2048DOI (Open Access)
-
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityIn: Nature Communications, Vol. 11, 2020, Nr. 1, 4684DOI (Open Access)
-
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsIn: Cell, Vol. 176, 2019, Nr. 3, pp. 505 – 519.e22DOI (Open Access)
-
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaIn: Nature Communications, Vol. 8, 2017, Nr. 1, 153DOI (Open Access)
-
B-cell-specific conditional expression of Myd88p.L²⁵²P leads to the development of diffuse large B-cell lymphoma in miceIn: Blood, Vol. 127, 2016, Nr. 22, pp. 2732 – 2741DOI (Open Access)
-
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerIn: Cell, Vol. 162, 2015, Nr. 1, pp. 146 – 159DOI (Open Access)
-
Comprehensive genomic profiles of small cell lung cancerIn: Nature, Vol. 524, 2015, Nr. 7563, pp. 47 – 53DOI (Open Access)
-
Erratum: A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerIn: Cell, Vol. 162, 2015, Nr. 5, pp. 1169DOI (Open Access)
-
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCIn: Cancer Discovery, Vol. 4, 2014, Nr. 5, pp. 592 – 605DOI (Open Access)
-
Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal StrengthIn: Cell, Vol. 135, 2008, Nr. 2, pp. 343 – 354DOI (Open Access)
-
14-3-3σ controls mitotic translation to facilitate cytokinesisIn: Nature, Vol. 446, 2007, Nr. 7133, pp. 329 – 332
-
p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageIn: Cancer Cell, Vol. 11, 2007, Nr. 2, pp. 175 – 189DOI (Open Access)
